<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Israeli stocks on Wall St</title>
    <link>https://www.globes.co.il/serveen/</link>
    <description>Keyword search for:</description>
    <copyright>Globes 2026</copyright>
    <language>en-us</language>
    <lastBuildDate>Wed, 15 Apr 2026 17:00:05 GMT</lastBuildDate>
    <ttl>10</ttl>
    <image>
      <height>40</height>
      <width>144</width>
      <link>https://www.globes.co.il/serveen/</link>
      <title>Israel's Business Arena</title>
      <url>https://www.globes.co.il/images/GlobesEN-144x40.gif</url>
    </image>
    <item>
      <title>Compugen was worth the wait  </title>
      <link>https://www.globes.co.il/en/article-1000868705</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000868705</guid>
      <description>Compugen shows life sciences companies that invest heavily in science can achieve a breakthrough, even after the capital market has given up on them.</description>
      <pubDate>Mon, 05 Aug 2013 16:46:00</pubDate>
    </item>
    <item>
      <title>Tower's share performance does not match its PR</title>
      <link>https://www.globes.co.il/en/article-1000832182</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000832182</guid>
      <description>Headlines provided by Tower give the impression that this is a manufacturer producing exceptional value for its investors.</description>
      <pubDate>Sun, 24 Mar 2013 15:54:00</pubDate>
    </item>
    <item>
      <title>Mellanox confounds expectations again  </title>
      <link>https://www.globes.co.il/en/article-1000816870</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000816870</guid>
      <description>Just as the growth was not completely clear, the explanations about the drop in performance are also inadequate.</description>
      <pubDate>Thu, 24 Jan 2013 16:03:01</pubDate>
    </item>
    <item>
      <title>NICE Systems and Verint Systems: 1+1=3</title>
      <link>https://www.globes.co.il/en/article-1000814358</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000814358</guid>
      <description>Such a deal could result in a company with annual revenue of $2 billion and improved profitability due to synergy.</description>
      <pubDate>Mon, 14 Jan 2013 19:47:00</pubDate>
    </item>
    <item>
      <title>After the coup, On Track faces uncertainty</title>
      <link>https://www.globes.co.il/en/article-1000813325</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000813325</guid>
      <description>After the success of the investor putsch, what does the future hold for the company and its employees?</description>
      <pubDate>Wed, 09 Jan 2013 19:55:00</pubDate>
    </item>
    <item>
      <title>Palo Alto challenges Check Point  </title>
      <link>https://www.globes.co.il/en/article-1000799816</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000799816</guid>
      <description>Palo Alto Networks' edge is not just in its approach, which targets more sophisticated contemporary challenges, but also in its hardware.</description>
      <pubDate>Tue, 20 Nov 2012 18:22:01</pubDate>
    </item>
    <item>
      <title>Mellanox muddles investors' minds </title>
      <link>https://www.globes.co.il/en/article-1000791329</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000791329</guid>
      <description>Mellanox says that it has a quarterly horizon for demand, and from this perspective, it emerges quite well from its guidance.</description>
      <pubDate>Fri, 19 Oct 2012 00:10:00</pubDate>
    </item>
    <item>
      <title>Haim Saban is not long term Partner investor</title>
      <link>https://www.globes.co.il/en/article-1000789839</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000789839</guid>
      <description>If an agreement to buy Partner is not concluded relatively swiftly, it is safe to assume that the deal will not be completed.</description>
      <pubDate>Sun, 14 Oct 2012 20:05:00</pubDate>
    </item>
    <item>
      <title>Hutchison leaves institutions with NIS 1.6b debt</title>
      <link>https://www.globes.co.il/en/article-1000776109</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000776109</guid>
      <description>Hutchison, like it or not, is still in the game, because of its $300 million seller's loan to Scailex when it acquired Partner in 2009</description>
      <pubDate>Sun, 26 Aug 2012 13:25:00</pubDate>
    </item>
    <item>
      <title>Given Imaging pill won't replace colonoscopy</title>
      <link>https://www.globes.co.il/en/article-1000772831</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000772831</guid>
      <description>Given Imaging told the US Food and Drug Administration (FDA) today that it will not be seeking the replacement of colonoscopies with its pill.</description>
      <pubDate>Wed, 08 Aug 2012 20:02:46</pubDate>
    </item>
    <item>
      <title>Levin sets scene for Teva cuts</title>
      <link>https://www.globes.co.il/en/article-1000771807</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000771807</guid>
      <description>New Teva CEO Dr. Jeremy Levin has already said that part of his strategy will be greater "budgetary discipline."</description>
      <pubDate>Sun, 05 Aug 2012 22:26:00</pubDate>
    </item>
    <item>
      <title>Mellanox bet well on high-speed  </title>
      <link>https://www.globes.co.il/en/article-1000767476</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000767476</guid>
      <description>Eyal Waldman made a good bet that InfiniBand would be the preferred solution for high-speed computing communications.</description>
      <pubDate>Thu, 19 Jul 2012 17:18:00</pubDate>
    </item>
    <item>
      <title>"Check Point is over-conservative"</title>
      <link>https://www.globes.co.il/en/article-1000763356</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000763356</guid>
      <description>Merrill Lynch's Tal Liani sees network security company Check Point's problems as internal. Others see external threats. What's certain is that the market is changing.</description>
      <pubDate>Thu, 05 Jul 2012 17:20:24</pubDate>
    </item>
    <item>
      <title>Cellcom throws down the gauntlet   </title>
      <link>https://www.globes.co.il/en/article-1000763058</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000763058</guid>
      <description>There is no question Cellcom's rivals must respond to their new plan, because this is no ordinary marketing move.</description>
      <pubDate>Thu, 05 Jul 2012 12:47:00</pubDate>
    </item>
    <item>
      <title>"I'd like to see Teva in India and China"</title>
      <link>https://www.globes.co.il/en/article-1000572982</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000572982</guid>
      <description>Teva chairman Dr. Phillip Frost talks about the pharmaceutical company's future and his own past.</description>
      <pubDate>Sun, 18 Jul 2010 19:59:00</pubDate>
    </item>
    <item>
      <title>An investment bank on steroids?</title>
      <link>https://www.globes.co.il/en/article-1000558271</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000558271</guid>
      <description>The SEC has called investment banking's biggest hitter a cheat. The allegations against Goldman Sachs may mean the capital market umpires becoming a whole lot stricter.</description>
      <pubDate>Tue, 11 May 2010 10:11:00</pubDate>
    </item>
    <item>
      <title>Ormat pins hopes in US geothermal bill  </title>
      <link>https://www.globes.co.il/en/article-1000213182</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1000213182</guid>
      <description>A House bill authorizes $400 million for geothermal research for fiscal years 2008-2012.</description>
      <pubDate>Sun, 27 May 2007 15:34:00</pubDate>
    </item>
    <item>
      <title>So when can I sell?</title>
      <link>https://www.globes.co.il/en/article-765352</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=765352</guid>
      <description>Everyone has heard of Rule 144 and Restricted Securities, but few understand the implications.</description>
      <pubDate>Tue, 27 Jan 2004 14:54:00</pubDate>
    </item>
    <item>
      <title>The Sarbanes-Oxley Act and you</title>
      <link>https://www.globes.co.il/en/article-615707</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=615707</guid>
      <description>How the legal response to the Enron affair will affect Israeli companies.</description>
      <pubDate>Tue, 27 Jan 2004 14:01:00</pubDate>
    </item>
  </channel>
</rss>